Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 49,350
-2,150 (-4.17%)
Apr 29, 2026, 2:30 PM KST
77.52% (1Y)
| Market Cap | 2.62T |
| Revenue (ttm) | 155.18B |
| Net Income (ttm) | -5.56B |
| Shares Out | 50.78M |
| EPS (ttm) | -109.48 |
| PE Ratio | n/a |
| Forward PE | 1,376.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 256,872 |
| Average Volume | 408,329 |
| Open | 51,100 |
| Previous Close | 51,500 |
| Day's Range | 48,700 - 51,800 |
| 52-Week Range | 24,000 - 66,600 |
| Beta | 0.91 |
| RSI | 51.13 |
| Earnings Date | May 13, 2026 |